As per BAT:
"BAT’s US bio-tech subsidiary, Kentucky BioProcessing (KBP), is developing a potential vaccine for COVID-19 and is now in pre-clinical testing. If testing goes well, BAT is hopeful that, with the right partners and support from government agencies, between 1 and 3 million doses of the vaccine could be manufactured per week, beginning in June.
While KBP remains a commercial operation, the intention is that its work around the COVID-19 vaccine project will be carried out on a not for profit basis.
The vaccine in development uses BAT’s proprietary, fast-growing tobacco plant technology which has several advantages over conventional vaccine production technology:
- It is potentially safer given that tobacco plants can’t host pathogens which cause human disease.
- It is faster because the elements of the vaccine accumulate in tobacco plants much more quickly – 6 weeks in tobacco plants versus several months using conventional methods.
- The vaccine formulation KBP is developing remains stable at room temperature, unlike conventional vaccines which often require refrigeration.
- It has the potential to deliver an effective immune response in a single dose. "
Smoking saves lives!
Visit The Orifice of Government Commerce and buy a collector's item.
Visit The Joy of Lard and indulge your lard fantasies.
Show your contempt for Nanny by buying a T shirt or thong from Nanny's Store.
www.nannyknowsbest.com is brought to you by www.kenfrost.com "The Living Brand"
Visit Oh So Swedish Swedish arts and handicrafts
Am working at Imperial Tobacco in Petone New Zealand , we are classed as an Essential Industry and are working through the 4 week nationwide lockdown! Yes for real!! Stuff Nanny!
ReplyDelete